TI - Real World Outcomes of First Line Pertuzumab Based Therapy in HER2 Positive Metastatic Breast Cancer: Performance Status, Metastatic Burden and Nutritional Status as Prognostic Factors
PT - Journal Article
DP - 2026
TA - EJMI
PG - 459-472
VI - 10
IP - 4
AID - 2612459 [doi]
4100 - https://dx.doi.org/10.14744/ejmi.2612459
SO - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION,2026 10(4): 459